Equity Capital And Reserves Cambio Fecha
Adcock Ingram Holdings ZAR 5.54B 131.19M 2024-12
Celltrion KRW 17.14T 298.25B 2025-03
Clinuvel Pharmaceuticals AUD 203.01M 24.36M 2024-06
Cochlear AUD 1.87B 27.1M 2024-12
CSL USD 20.55B 3.18B 2024-12
Cspc Pharmaceutical CNY 32.26B 2.59B 2024-12
Dianthus Therapeutics USD 303.08M 49.4M 2025-06
Divis Laboratories Ltd 149.69B 12.52B 2025-03
Kangmei Pharma CNY 7.73B 546.26M 2025-06
Knight Therapeutics CAD 773.91M 11.11M 2024-09
Laboratorios Farma EUR 574.72M 6.82M 2025-06
Malin Corporation EUR 193.2M 75M 2024-12
Mayne Pharma AUD 454.19M 93.58M 2024-06
Medical Developments International AUD 55.33M 9.6M 2024-12
Nanosonics AUD 189.03M 6.82M 2024-12
Neuren Pharmaceuticals AUD 363.9M 144.75M 2024-12
Organigram Holdings CAD 385.5M 61.85M 2025-06
Pacific Edge NZD 26.08M 14.57M 2025-03
Paradigm Biopharmaceuticals AUD 34.06M 10.25M 2024-12
Pharma Mar EUR 201.53M 4.06M 2025-06
Polynovo AUD 72.12M 3.07M 2024-06
PYC Therapeutics AUD 55.44M 25.62M 2024-12
Qiagen NV USD 3.51B 97.61M 2025-06
Ramsay Health Care AUD 4.81B 82.9M 2024-12
ResMed USD 5.97B 714.85M 2025-06
Sartorius EUR 2.66B 51.3M 2025-06
Sino Biopharmaceutical CNY 31.96B 884.2M 2024-12
Telix Pharmaceuticals AUD 568.21M 164.24M 2024-12
Tilray USD 3.47B 5.16M 2024-11
Zz Pientze Pharmaceu 14.65B 617.48M 2025-06


Avita Medical Capital Y Las Reservas - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Sep 2025.